NCT06883123View on ClinicalTrials.gov

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Open Angle Glaucoma
Interventions
DRUG

Simbrinza 0.2%-1% Ophthalmic Suspension

brinzolamide and brimonidine tartrate

DRUG

Rocklatan 0.02%-0.005% Ophthalmic Solution

netarsudil and latanoprost

DRUG

Cosopt PF 2%-0.5% Ophthalmic Solution

dorzolamide hydrochloride and timolol maleate

DRUG

Latanoprost 0.005% Ophthalmic Solution

Latanoprost

Trial Locations (1)

62704

RECRUITING

Prairie Eye Center, Springfield

All Listed Sponsors
collaborator

Sengi

INDUSTRY

lead

Prairie Eye Center

OTHER